Can Recursion Pharmaceuticals Inc (RXRX) stock recover despite sales dropping?
In yesterday’s Wall Street session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares traded at $5.06, up 0.60% from the previous session. RXRX stock price is now 3.03% away from the 50-day moving average and -20.12% away from the 200-day moving average. The market capitalization of the company currently stands at $2.06B. With the price target of $8, […]
Do futuristic bulls still own Recursion Pharmaceuticals Inc [RXRX] stock?
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares traded -3.98%% lower at $4.83 on Wall Street last session. RXRX stock price is now -2.00% away from the 50-day moving average and -24.04% away from the 200-day moving average. The market capitalization of the company currently stands at $1.96B. With the price target of $8, Morgan Stanley recently initiated […]
Is Recursion Pharmaceuticals Inc (NASDAQ:RXRX) being unfairly punished by investors?
In Monday’s Wall Street session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares traded at $5.00, up 1.63% from the previous session. RXRX stock price is now 2.60% away from the 50-day moving average and -21.88% away from the 200-day moving average. The market capitalization of the company currently stands at $2.03B. With the price target of $8, […]
A Stock With Stellar Fundamentals? Recursion Pharmaceuticals Inc (NASDAQ:RXRX): Is It Right For You?
In Thursday’s Wall Street session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares traded at $5.40, down -0.92% from the previous session. RXRX stock price is now 10.76% away from the 50-day moving average and -16.17% away from the 200-day moving average. The market capitalization of the company currently stands at $2.20B. With the price target of $8, […]
Do you still think Recursion Pharmaceuticals Inc (NASDAQ:RXRX) is worth a look?
Stocks of Recursion Pharmaceuticals Inc (NASDAQ:RXRX) traded higher last session on Wall Street, up 4.55% to $4.37. RXRX stock price is now -13.10% away from the 50-day moving average and -32.86% away from the 200-day moving average. The market capitalization of the company currently stands at $1.78B. With the price target of $8, Morgan Stanley […]
Do investors have a safe investment in Recursion Pharmaceuticals Inc (NASDAQ:RXRX)?
The price of Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares last traded on Wall Street rose 0.11% to $4.39. RXRX stock price is now -14.79% away from the 50-day moving average and -32.77% away from the 200-day moving average. The market capitalization of the company currently stands at $1.79B. With the price target of $8, Morgan Stanley […]
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) Risks You Should Know Before Investing
In Monday’s Wall Street session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares traded at $4.51, down -1.10% from the previous session. RXRX stock price is now -16.40% away from the 50-day moving average and -31.81% away from the 200-day moving average. The market capitalization of the company currently stands at $1.83B. With the price target of $8, […]
The most important numbers to know about Recursion Pharmaceuticals Inc (NASDAQ:RXRX)
The stock of Recursion Pharmaceuticals Inc (NASDAQ:RXRX) last traded at $4.64, up 7.16% from the previous session. RXRX stock price is now -17.16% away from the 50-day moving average and -30.82% away from the 200-day moving average. The market capitalization of the company currently stands at $1.89B. With the price target of $8, Morgan Stanley […]
There is little time left for Recursion Pharmaceuticals Inc (RXRX) to reach its 1-year target estimate. How soon will it surpass it?
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares traded -16.58% lower at $4.76 on Wall Street last session. RXRX stock price is now -20.49% away from the 50-day moving average and -30.06% away from the 200-day moving average. The market capitalization of the company currently stands at $1.91B. With the price target of $8, Morgan Stanley recently initiated […]
Recursion Pharmaceuticals Inc (NASDAQ:RXRX): A Fundamentally Weighted Stock for Long-Term Investors
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares traded -2.05% lower at $5.72 on Wall Street last session. RXRX stock price is now -10.23% away from the 50-day moving average and -16.59% away from the 200-day moving average. The market capitalization of the company currently stands at $2.30B. With the price target of $8, Morgan Stanley recently initiated […]